There’s a rapidly expanding market for new DNA tests aimed at helping seemingly healthy people gain insights into their risk of developing all sorts of diseases.

The latest entrant, launched on Tuesday, promises to analyze a canonical list of 59 genes that influence your likelihood of developing certain cancers and heart problems, along with other conditions. The new GenePrism test comes from PerkinElmer, a Massachusetts diagnostics company, and Helix, a Silicon Valley startup that’s developed something of an app store for DNA tests.

Unlock this article by subscribing to STAT Plus and enjoy your first 30 days free!


What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Daily Recap newsletter

A roundup of STAT’s top stories of the day in science and medicine

Privacy Policy